Indicators

Markets:

News

Latest News about Merck & Co Inc

Recent news which mentions Merck & Co Inc

< Previous 1 2 3 4 5 6 7 8 Next >

Pharma is hopeful about Trump's second term — here's what to expect for drugmakers

January 26, 2025

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

January 17, 2025

Jim Cramer says he supports healthcare stocks for their long-term value

January 14, 2025

Merck CEO talks medicines beyond the company's top cancer drug

January 14, 2025

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

January 14, 2025

Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market

January 08, 2025

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

December 18, 2024

Friday's big stock stories: What’s likely to move the market in the next trading session

November 14, 2024

Jim Cramer names hot sectors that could use a pullback

November 14, 2024

Cramer's Lighting Round: S&P Global is a buy

November 05, 2024

Black business leaders make a final push for Harris' economic plans to Black men

November 01, 2024

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

October 31, 2024

5 things to know before the stock market opens Monday

October 28, 2024

Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon

October 25, 2024

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

October 17, 2024

Cramer's Lightning Round: 'I like Target right here'

October 08, 2024

Tuesday's big stock stories: What’s likely to move the market in the next trading session

September 09, 2024

88 corporate leaders endorse Harris in new letter, including CEOs of Yelp, Box and Ripple

September 06, 2024

What's next for the Biden administration's Medicare drug price negotiations

August 15, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Thursday's big stock stories: What’s likely to move the market in the next trading session

August 14, 2024

Cramer's Lightning Round: Merck is a buy

August 08, 2024

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

August 01, 2024

Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda

July 30, 2024

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

July 23, 2024

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

July 16, 2024

FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

June 17, 2024

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

June 07, 2024

Moderna, Merck say vaccine improved survival in patients with deadly skin cancer

June 03, 2024

Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference

May 30, 2024

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.